BIO-key International, Inc. (BKYI)
- Previous Close
0.8361 - Open
0.8800 - Bid 0.8484 x 100
- Ask 0.9294 x 100
- Day's Range
0.8397 - 0.8800 - 52 Week Range
0.5200 - 4.5000 - Volume
22,171 - Avg. Volume
4,931,762 - Market Cap (intraday)
2.752M - Beta (5Y Monthly) 0.25
- PE Ratio (TTM)
-- - EPS (TTM)
-6.1100 - Earnings Date Nov 14, 2024
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
3.00
BIO-key International, Inc. develops and markets fingerprint identification biometric technology and software solutions, and enterprise-ready identity access management solutions for commercial, government, and education customers in the United States and internationally. The company offers BIO-key PortalGuard and PortalGuard IDaaS solutions, a customer-controlled and neutral-by-design cloud-based identity platform that allows customers to integrate with any cloud or on-premises SaaS application, services and cloud host, as well as windows device authentication through IAM platform. Its solutions enable its customers to secure their workforces and student populations; and make their partner networks more collaborative. In addition, it provides BIO-key VST and WEB-key products; and Civil and Large-Scale ID Infrastructure solutions that develops finger-based biometric technology. Further, it offers finger scanners for enterprise and consumer markets under SideSwipe, EcoID, and SidePass brand names. The company was formerly known as SAC Technologies and changed its name to BIO-key International, Inc. in 2002. BIO-key International, Inc. was founded in 1993 and is headquartered in Holmdel, New Jersey.
www.bio-key.comRecent News: BKYI
View MorePerformance Overview: BKYI
Trailing total returns as of 11/22/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BKYI
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BKYI
View MoreValuation Measures
Market Cap
2.61M
Enterprise Value
3.28M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.16
Price/Book (mrq)
19.65
Enterprise Value/Revenue
0.45
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-91.72%
Return on Assets (ttm)
-55.68%
Return on Equity (ttm)
-458.11%
Revenue (ttm)
6.96M
Net Income Avi to Common (ttm)
-6.39M
Diluted EPS (ttm)
-6.1100
Balance Sheet and Cash Flow
Total Cash (mrq)
1.26M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
2.71M